InfuSystem (INFU) Competitors $10.13 +0.07 (+0.70%) Closing price 10/24/2025 04:00 PM EasternExtended Trading$10.18 +0.05 (+0.49%) As of 10/24/2025 06:04 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock INFU vs. AXGN, SIBN, BFLY, BVS, ZIMV, AVNS, CBLL, KIDS, DCTH, and TMCIShould you be buying InfuSystem stock or one of its competitors? The main competitors of InfuSystem include AxoGen (AXGN), SiBone (SIBN), Butterfly Network (BFLY), Bioventus (BVS), ZimVie (ZIMV), AVANOS MEDICAL (AVNS), CeriBell (CBLL), OrthoPediatrics (KIDS), Delcath Systems (DCTH), and Treace Medical Concepts (TMCI). These companies are all part of the "medical equipment" industry. InfuSystem vs. Its Competitors AxoGen SiBone Butterfly Network Bioventus ZimVie AVANOS MEDICAL CeriBell OrthoPediatrics Delcath Systems Treace Medical Concepts InfuSystem (NYSE:INFU) and AxoGen (NASDAQ:AXGN) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their institutional ownership, analyst recommendations, profitability, risk, dividends, earnings, media sentiment and valuation. Does the media prefer INFU or AXGN? In the previous week, AxoGen had 5 more articles in the media than InfuSystem. MarketBeat recorded 6 mentions for AxoGen and 1 mentions for InfuSystem. InfuSystem's average media sentiment score of 1.94 beat AxoGen's score of 0.52 indicating that InfuSystem is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment InfuSystem 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive AxoGen 1 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Which has stronger valuation & earnings, INFU or AXGN? InfuSystem has higher earnings, but lower revenue than AxoGen. AxoGen is trading at a lower price-to-earnings ratio than InfuSystem, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioInfuSystem$139.89M1.48$870K$0.2344.04AxoGen$203.27M4.11-$9.96M-$0.10-181.70 Do analysts rate INFU or AXGN? InfuSystem presently has a consensus target price of $13.50, suggesting a potential upside of 33.27%. AxoGen has a consensus target price of $25.75, suggesting a potential upside of 41.72%. Given AxoGen's higher probable upside, analysts plainly believe AxoGen is more favorable than InfuSystem.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score InfuSystem 0 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 3 Strong Buy rating(s) 3.40AxoGen 1 Sell rating(s) 0 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 2.60 Do insiders and institutionals hold more shares of INFU or AXGN? 71.1% of InfuSystem shares are held by institutional investors. Comparatively, 80.3% of AxoGen shares are held by institutional investors. 11.4% of InfuSystem shares are held by company insiders. Comparatively, 2.8% of AxoGen shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term. Is INFU or AXGN more profitable? InfuSystem has a net margin of 1.12% compared to AxoGen's net margin of -2.29%. InfuSystem's return on equity of 2.78% beat AxoGen's return on equity.Company Net Margins Return on Equity Return on Assets InfuSystem1.12% 2.78% 1.41% AxoGen -2.29%-4.43%-2.34% Which has more volatility and risk, INFU or AXGN? InfuSystem has a beta of 1.79, indicating that its share price is 79% more volatile than the S&P 500. Comparatively, AxoGen has a beta of 1.04, indicating that its share price is 4% more volatile than the S&P 500. SummaryInfuSystem beats AxoGen on 11 of the 17 factors compared between the two stocks. Get InfuSystem News Delivered to You Automatically Sign up to receive the latest news and ratings for INFU and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding INFU and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart INFU vs. The Competition Export to ExcelMetricInfuSystemSurgical & medical instruments IndustryMedical SectorNYSE ExchangeMarket Cap$206.92M$69.71M$6.25B$21.99BDividend YieldN/AN/A5.71%3.57%P/E Ratio168.8612.3330.8333.34Price / Sales1.4830.00562.4293.03Price / Cash12.7918.4137.0824.54Price / Book4.1013.7312.054.66Net Income$870K-$27.23M$3.33B$1.02B7 Day Performance12.56%-3.20%1.88%2.22%1 Month Performance0.50%1.42%7.70%2.07%1 Year Performance55.01%42.83%56.33%14.05% InfuSystem Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)INFUInfuSystem4.0341 of 5 stars$10.13+0.7%$13.50+33.3%+54.0%$206.92M$139.89M168.86410Positive NewsShort Interest ↑AXGNAxoGen3.5294 of 5 stars$16.03+2.8%$25.75+60.7%+36.5%$735.93M$187.34M-159.93450Upcoming EarningsAnalyst ForecastSIBNSiBone3.6991 of 5 stars$15.22+1.8%$23.67+55.5%+22.8%$656.16M$167.18M-27.16350Analyst ForecastBFLYButterfly Network2.656 of 5 stars$2.30-0.2%$3.00+30.7%+26.4%$577.49M$82.06M-8.19460Upcoming EarningsAnalyst ForecastGap UpBVSBioventus0.8707 of 5 stars$6.68+1.7%N/AN/A$552.30M$573.28M13.021,200News CoverageAnalyst ForecastZIMVZimVie0.6177 of 5 stars$18.98+0.0%$17.75-6.5%+34.2%$535.29M$449.75M-27.111,770Upcoming EarningsAVNSAVANOS MEDICAL2.4857 of 5 stars$10.94+0.9%N/A-46.9%$507.06M$687.80M-1.092,227News CoverageUpcoming EarningsCBLLCeriBell2.505 of 5 stars$12.47+4.0%$32.14+157.9%N/A$456.97M$65.44M-4.17N/ANews CoverageAnalyst ForecastKIDSOrthoPediatrics4.5089 of 5 stars$17.96+2.6%$26.29+46.4%-33.5%$448.73M$204.73M-10.00200Upcoming EarningsDCTHDelcath Systems2.7087 of 5 stars$11.44+0.8%$24.50+114.2%-3.9%$400.17M$37.21M228.8060News CoverageAnalyst ForecastAnalyst RevisionTMCITreace Medical Concepts2.1473 of 5 stars$6.20+3.3%$9.83+58.6%+39.4%$387.86M$209.36M-7.77250News CoverageAnalyst Forecast Related Companies and Tools Related Companies AXGN Competitors SIBN Competitors BFLY Competitors BVS Competitors ZIMV Competitors AVNS Competitors CBLL Competitors KIDS Competitors DCTH Competitors TMCI Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:INFU) was last updated on 10/25/2025 by MarketBeat.com Staff From Our PartnersNEW LAW: Congress Approves Setup For Digital Dollar?Trump Ally Says Congress Approved the Setup for a Digital Dollar 2.0 But according to Rep. Marjorie Taylor ...Goldco Precious Metals | SponsoredIf You Keep Cash In A U.S. Bank Account… Read This NOWThe Treasury Department just issued a stunning warning: U.S. banks could lose up to $6.6 trillion of custom...Banyan Hill Publishing | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored$100 Trillion “AI Metal” Found in American Ghost TownJeff Brown recently traveled to a ghost town in the middle of an American desert… To investigate what could...Brownstone Research | SponsoredClaim Your Share of $5.39 BILLION in AI Equity ChecksThe U.S. government just took advantage of Public Law 81-774 to crack down on AI companies... In turn, enfo...Angel Publishing | SponsoredMove $1,000 into this stock before Nov 6The End of Tesla? "Hold onto your Tesla stock." That's the message insiders at Tesla have been giving staff...Altimetry | Sponsored$4,200 gold is nice ... but here’s what most gold bugs are missingGold just surged past $4,200, but Weiss Ratings expert Sean Brodrick says the real upside is in select gold st...Weiss Ratings | SponsoredBuy UBER immediatelyBULLISH: It's time to buy this 'hidden' AI stock An award-winning stock-rating system has turned BULLISH on...Chaikin Analytics | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding InfuSystem Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share InfuSystem With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free INFU Stock Alerts